NO891470D0 - Fremgangsmaate for fremstilling av nye substituerte azetidinoner. - Google Patents
Fremgangsmaate for fremstilling av nye substituerte azetidinoner.Info
- Publication number
- NO891470D0 NO891470D0 NO891470A NO891470A NO891470D0 NO 891470 D0 NO891470 D0 NO 891470D0 NO 891470 A NO891470 A NO 891470A NO 891470 A NO891470 A NO 891470A NO 891470 D0 NO891470 D0 NO 891470D0
- Authority
- NO
- Norway
- Prior art keywords
- procedure
- preparation
- new substituted
- substituted azetidinones
- azetidinones
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing alicyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Reinforced Plastic Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17968888A | 1988-04-11 | 1988-04-11 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO891470D0 true NO891470D0 (no) | 1989-04-10 |
| NO891470L NO891470L (no) | 1989-10-12 |
Family
ID=22657566
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO89891470A NO891470L (no) | 1988-04-11 | 1989-04-10 | Fremgangsmaate for fremstilling av nye substituerte azetidinoner. |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP0337549B1 (no) |
| JP (1) | JP2736113B2 (no) |
| KR (1) | KR930008223B1 (no) |
| CN (1) | CN1037144A (no) |
| AT (1) | ATE128704T1 (no) |
| AU (1) | AU621865B2 (no) |
| CA (1) | CA1337990C (no) |
| DE (1) | DE68924439T2 (no) |
| DK (1) | DK169329B1 (no) |
| ES (1) | ES2079373T3 (no) |
| FI (1) | FI891689A (no) |
| GR (1) | GR3017656T3 (no) |
| HU (1) | HUT50761A (no) |
| IE (1) | IE891140L (no) |
| IL (1) | IL89835A0 (no) |
| LV (1) | LV11459B (no) |
| NO (1) | NO891470L (no) |
| NZ (1) | NZ228600A (no) |
| PT (1) | PT90222B (no) |
| YU (1) | YU71489A (no) |
| ZA (1) | ZA892549B (no) |
Families Citing this family (54)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5229510A (en) * | 1983-12-01 | 1993-07-20 | Merck & Co., Inc. | β-lactams useful in determining the amount of elastase in a clinical sample |
| US5229381A (en) * | 1983-12-01 | 1993-07-20 | Merck & Co., Inc. | Substituted azetidinones as anti-inflammatory and antidegenerative agents |
| IL99658A0 (en) * | 1990-10-15 | 1992-08-18 | Merck & Co Inc | Substituted azetidinones and pharmaceutical compositions containing them |
| GB9103654D0 (en) * | 1991-02-21 | 1991-04-10 | Merck Sharp & Dohme | Chemical process |
| US5100880A (en) * | 1991-03-20 | 1992-03-31 | Merck & Co., Inc. | Novel betalactam elastase inhibitors containing phosphorous acid derivatives at the 4-position of the 2-azetidinone |
| US5104862A (en) * | 1991-03-20 | 1992-04-14 | Merck & Co., Inc. | Bethalactam elastase inhibitors containing phosphorous acid derivatives at the 4-position of the 2-azetidinone |
| EP0533951A4 (en) * | 1991-04-10 | 1993-09-01 | Japan Tobacco Inc. | Novel oxazinone derivative |
| WO1993000332A1 (en) * | 1991-06-25 | 1993-01-07 | Merck & Co., Inc. | Substituted azetidinones as anti-inflammatory and antidegenerative agents |
| US5348953A (en) * | 1991-06-25 | 1994-09-20 | Merck & Co., Inc. | Substituted azetidinones as anti-inflammatory and antidegenerative agents |
| US5688785A (en) * | 1991-07-23 | 1997-11-18 | Schering Corporation | Substituted azetidinone compounds useful as hypocholesterolemic agents |
| TW223059B (no) * | 1991-07-23 | 1994-05-01 | Schering Corp | |
| US5688787A (en) * | 1991-07-23 | 1997-11-18 | Schering Corporation | Substituted β-lactam compounds useful as hypochlesterolemic agents and processes for the preparation thereof |
| EP0529719A1 (en) * | 1991-08-26 | 1993-03-03 | Merck & Co. Inc. | Assay for evaluating inhibition of PMN elastase by N-Substituted Azetidinones |
| US5229267A (en) * | 1991-08-26 | 1993-07-20 | Merck & Co., Inc. | Assay for evaluating inhibition of PMN elastase by N-substituted azetidinones |
| US5274080A (en) * | 1991-08-26 | 1993-12-28 | Merck & Co., Inc. | Monospecific antibodies useful in evaluating inhibition of polymorphonuclear leukocyte elastase by N-substituted azetidinones |
| US5276139A (en) * | 1991-08-26 | 1994-01-04 | Merck & Co., Inc. | Haptens useful in evaluating inhibition of PNN elastase by N-substituted azetidinones |
| US5149838A (en) * | 1991-09-20 | 1992-09-22 | Merck & Co., Inc. | Intermediates for substituted azetidinones useful as anti-inflammatory and antidegenerative agents |
| GB2266527A (en) * | 1992-03-17 | 1993-11-03 | Merck & Co Inc | Substituted azetidinones useful in the treatment of leukemia |
| US5250676A (en) * | 1992-03-23 | 1993-10-05 | University Of Notre Dame Du Lac | Process for the preparation of 3-substituted-2-azetidinones |
| CA2108584C (en) * | 1992-10-27 | 1998-11-24 | James B. Doherty | Substituted azetidinones as anti-inflammatory and antidegenerative agents |
| EP0666846A1 (en) * | 1992-10-27 | 1995-08-16 | Merck & Co. Inc. | New substituted azetidinones as anti-inflammatory and antidegenerative agents |
| WO1994013636A1 (en) * | 1992-12-17 | 1994-06-23 | Merck & Co., Inc. | New substituted azetidinones as anti-inflammatory and antidegenerative agents |
| US5591737A (en) * | 1992-12-17 | 1997-01-07 | Merck & Co., Inc. | Substituted azetidinones as anti-inflammatory and antidegenerative agents |
| LT3595B (en) | 1993-01-21 | 1995-12-27 | Schering Corp | Spirocycloalkyl-substituted azetidinones useful as hypocholesterolemic agents |
| GB9314350D0 (en) * | 1993-07-12 | 1993-08-25 | Zeneca Ltd | Armide derivatives |
| US5420010A (en) * | 1993-07-30 | 1995-05-30 | Merck & Co., Inc. | Assay for evaluating inhibition of polymorphonuclear leukocyte elastase by N-substituted azetidinones |
| US5631365A (en) | 1993-09-21 | 1997-05-20 | Schering Corporation | Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents |
| US5403952A (en) * | 1993-10-08 | 1995-04-04 | Merck & Co., Inc. | Substituted cyclic derivatives as novel antidegenerative agents |
| JPH09510212A (ja) * | 1994-03-11 | 1997-10-14 | メルク エンド カンパニー インコーポレーテッド | 肺疾患を処置するための組成物 |
| US5627176A (en) * | 1994-03-25 | 1997-05-06 | Schering Corporation | Substituted azetidinone compounds useful as hypocholesterolemic agents |
| US5633246A (en) * | 1994-11-18 | 1997-05-27 | Schering Corporation | Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents |
| US5624920A (en) * | 1994-11-18 | 1997-04-29 | Schering Corporation | Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents |
| US5656624A (en) * | 1994-12-21 | 1997-08-12 | Schering Corporation | 4-[(heterocycloalkyl or heteroaromatic)-substituted phenyl]-2-azetidinones useful as hypolipidemic agents |
| WO1996029307A1 (fr) * | 1995-03-23 | 1996-09-26 | Japan Tobacco Inc. | Composes de diphenylmethyle-azetidinone et inhibiteur d'elastase |
| US5747485A (en) * | 1995-04-13 | 1998-05-05 | Merck & Co., Inc. | Substituted azetidiones as anti-inflammatory and antidegenerative agents |
| US5523233A (en) * | 1995-05-03 | 1996-06-04 | Merck & Co., Inc. | Enzymatic hydrolysis of 3,3-diethyl-4-[(4-carboxy)phenoxy]-2-azetidinone esters |
| JP2002515852A (ja) * | 1995-07-01 | 2002-05-28 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | アテローム性動脈硬化症の治療のためのアゼチジノン誘導体 |
| AU7222196A (en) * | 1995-10-09 | 1997-04-30 | Chiroscience Limited | Azetidinones and their therapeutic use as cytokine inhibitors |
| WO1997021675A1 (en) * | 1995-12-08 | 1997-06-19 | Smithkline Beecham Plc | Monocyclic beta-lactame derivatives for treatment of atherosclerosis |
| CA2252696A1 (en) * | 1996-04-26 | 1997-11-06 | Deirdre Mary Bernadette Hickey | Azetidinone derivatives for the treatment of atherosclerosis |
| US5756470A (en) * | 1996-10-29 | 1998-05-26 | Schering Corporation | Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents |
| US6903075B1 (en) | 1997-05-29 | 2005-06-07 | Merck & Co., Inc. | Heterocyclic amide compounds as cell adhesion inhibitors |
| ATE230725T1 (de) * | 1997-10-07 | 2003-01-15 | Boehringer Ingelheim Ca Ltd | Azetidinonderivate zur behandlung von hcmv entzündungen |
| WO1999018073A1 (en) * | 1997-10-07 | 1999-04-15 | Boehringer Ingelheim (Canada) Ltd. | Azetidinone derivatives for the treatment of hcmv infections |
| US6242439B1 (en) * | 1997-10-07 | 2001-06-05 | Boehringer Ingelheim (Canada) Ltd. | Azetidinone derivatives for the treatment of HCMV infections |
| AU8059598A (en) * | 1998-06-11 | 1999-12-30 | Merck & Co., Inc. | Heterocyclic amide compounds as cell adhesion inhibitors |
| US6335324B1 (en) | 1998-06-25 | 2002-01-01 | Bristol-Myers Squibb Co. | Beta lactam compounds and their use as inhibitors of tryptase |
| AU4654199A (en) * | 1998-07-23 | 2000-02-14 | Shionogi & Co., Ltd. | Monocyclic beta-lactam compounds and chymase inhibitors containing the same |
| AR023463A1 (es) | 1999-04-16 | 2002-09-04 | Schering Corp | Uso de compuestos de azetidinona |
| IL157552A0 (en) | 2001-03-28 | 2004-03-28 | Schering Corp | Enantioselective synthesis of azetidinone intermediate compounds |
| US7056906B2 (en) | 2001-09-21 | 2006-06-06 | Schering Corporation | Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women |
| DE602004018617D1 (de) | 2003-03-07 | 2009-02-05 | Schering Corp | Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia |
| MXPA05009503A (es) | 2003-03-07 | 2005-10-18 | Schering Corp | Compuestos de azetidinona sustituidos, formulaciones y usos de los mismos para el tratamiento de hipercolesterolemia. |
| US8440819B2 (en) * | 2008-02-22 | 2013-05-14 | Allergan, Inc. | Therapeutic substituted beta-lactams |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4680391A (en) * | 1983-12-01 | 1987-07-14 | Merck & Co., Inc. | Substituted azetidinones as anti-inflammatory and antidegenerative agents |
-
1989
- 1989-04-04 NZ NZ228600A patent/NZ228600A/en unknown
- 1989-04-04 IL IL89835A patent/IL89835A0/xx unknown
- 1989-04-06 AT AT89200864T patent/ATE128704T1/de not_active IP Right Cessation
- 1989-04-06 ES ES89200864T patent/ES2079373T3/es not_active Expired - Lifetime
- 1989-04-06 DE DE68924439T patent/DE68924439T2/de not_active Expired - Fee Related
- 1989-04-06 EP EP89200864A patent/EP0337549B1/en not_active Expired - Lifetime
- 1989-04-07 ZA ZA892549A patent/ZA892549B/xx unknown
- 1989-04-07 CA CA000595997A patent/CA1337990C/en not_active Expired - Fee Related
- 1989-04-07 PT PT90222A patent/PT90222B/pt not_active IP Right Cessation
- 1989-04-10 CN CN89103271A patent/CN1037144A/zh active Pending
- 1989-04-10 DK DK170589A patent/DK169329B1/da not_active IP Right Cessation
- 1989-04-10 KR KR1019890004702A patent/KR930008223B1/ko active IP Right Grant
- 1989-04-10 AU AU32630/89A patent/AU621865B2/en not_active Ceased
- 1989-04-10 YU YU00714/89A patent/YU71489A/xx unknown
- 1989-04-10 NO NO89891470A patent/NO891470L/no unknown
- 1989-04-10 IE IE891140A patent/IE891140L/xx not_active IP Right Cessation
- 1989-04-10 FI FI891689A patent/FI891689A/fi not_active Application Discontinuation
- 1989-04-10 HU HU891708A patent/HUT50761A/hu unknown
- 1989-04-11 JP JP1091723A patent/JP2736113B2/ja not_active Expired - Fee Related
-
1995
- 1995-10-05 GR GR950402512T patent/GR3017656T3/el unknown
-
1996
- 1996-02-01 LV LVP-96-24A patent/LV11459B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ228600A (en) | 1992-02-25 |
| PT90222B (pt) | 1994-07-29 |
| LV11459A (lv) | 1996-08-20 |
| DK169329B1 (da) | 1994-10-10 |
| AU3263089A (en) | 1989-10-12 |
| DK170589A (da) | 1989-10-12 |
| KR930008223B1 (ko) | 1993-08-27 |
| ES2079373T3 (es) | 1996-01-16 |
| NO891470L (no) | 1989-10-12 |
| CA1337990C (en) | 1996-01-23 |
| EP0337549B1 (en) | 1995-10-04 |
| ZA892549B (en) | 1989-11-29 |
| GR3017656T3 (en) | 1996-01-31 |
| DK170589D0 (da) | 1989-04-10 |
| IE891140L (en) | 1989-10-11 |
| CN1037144A (zh) | 1989-11-15 |
| HUT50761A (en) | 1990-03-28 |
| FI891689A (fi) | 1989-10-12 |
| ATE128704T1 (de) | 1995-10-15 |
| FI891689A0 (fi) | 1989-04-10 |
| DE68924439T2 (de) | 1996-05-09 |
| PT90222A (pt) | 1989-11-10 |
| LV11459B (en) | 1996-12-20 |
| DE68924439D1 (de) | 1995-11-09 |
| JP2736113B2 (ja) | 1998-04-02 |
| IL89835A0 (en) | 1989-12-15 |
| YU71489A (en) | 1991-10-31 |
| JPH026471A (ja) | 1990-01-10 |
| EP0337549A1 (en) | 1989-10-18 |
| KR900016121A (ko) | 1990-11-12 |
| AU621865B2 (en) | 1992-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO891470D0 (no) | Fremgangsmaate for fremstilling av nye substituerte azetidinoner. | |
| ES553821A0 (es) | Un procedimiento para la preparacion de nuevas azetidinonas sustituidas. | |
| ES2053864T3 (es) | Derivados de acido 4-(quinolin-2-il-metoxi)fenil-acetico substituido. | |
| DK0435321T3 (da) | Nye A-nor-steroid-3-carboxylsyrederivater | |
| NO170023C (no) | Analogifremgangsmaate for fremstilling av nye terapeutisk aktive alfa-glucosidaseinhibitorer | |
| NO914027D0 (no) | Fremgangsmaate for fremstilling av nye substituerte azetidinoner | |
| GR900100380A (el) | Μέ?οδος παρασκευής αντι-φλεγμονωδών παραγώγων αμινοφενόλης. | |
| NO174467C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive kromanderivater | |
| NO874699D0 (no) | Fremgangsmaate for frenstilling av nye substituerte cefalosporin-sulfoner. | |
| NO900742L (no) | Sammenstilling av verktoeydeler. | |
| MY128261A (en) | New substituted azetidinones as anti-inflammatory and antidegenerative agents | |
| NO174422C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive kromanderivater | |
| NO177712C (no) | Analogifremgangsmåte for fremstilling av nye terapeutisk virksomme alkylfosfonoseriner | |
| FI901550A0 (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten di-imidatsopyrimidiini- ja imidatsopyratsolopyrimidiinijohdannaisten valmistamiseksi | |
| GR880100196A (el) | Υποκατεστημενα 1,3-διοξολαν-και 1,3-διοξαν-παραγωγα,μεθοδοι για την παρασκευη τους και η χρηση τους | |
| NO893006L (no) | Fremgangsmaate for fremstilling av nye allylaminoetylazoler | |
| NO177274C (no) | Apparat for destrukturering av treflis | |
| NO884901D0 (no) | Fremgangsmaate for fremstilling av nye indenofuranderivater | |
| SE8904299D0 (sv) | Anordning foer fastspaenning av arbetsstycken |